Cellectar Biosciences (NASDAQ:CLRB) is preparing to release its quarterly earnings on Thursday, 2025-08-14. Here’s a brief overview of what investors should keep in mind before the announcement.

Analysts expect Cellectar Biosciences to report an earnings per share (EPS) of $-3.66.

Investors in Cellectar Biosciences are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It’s …

Full story available on Benzinga.com